Slides
Page 1
JENOPTIK MORE LIGHT JENOPTIK AG - First half - year 2026 Dr. Dominic Dorfner , CEO I Dr. Prisca Havranek - Kosicek , CFO I August 12 , 2026 © Copyright Jenoptik . All rights reserved .
Page 2
2.01 5,11 3.10 7,88 3.32 8,43 6.23 15,83 6.23 15,82 This presentation can contain forward-looking statements that are based on current expectations and certain assumptions of the management of the Jenoptik Group. A variety of known and unknown risks, uncertainties and other factors can cause the actual results, the financial situation, the development or the performance of the company to be materially different from the announced forward-looking statements. Such factors can be, among others, geopolitical conflicts, pandemic diseases, changes in currency exchange rates and interest rates, energy supply, the introduction of competing products or the change of the business strategy. The company does not assume any obligation to update such forward-looking statements in this document in the light of future developments. Disclaimer 2First half-year 202612.08.2026
Page 3
2.01 5,11 3.10 7,88 3.32 8,43 6.23 15,83 6.23 15,82 First half-year 2026
Page 4
2.01 5,11 3.10 7,88 3.32 8,43 6.23 15,83 6.23 15,82 High order intake dynamics continues into second quarter 12.08.2026 First half-year 2026 4 Business development: − Exceptionally strong demand in the OEM businesses, both in semiconductor equipment and biophotonics − Revenue slightly up year-on-year − EBITDA margin significantly improved − Free cash flow influenced by demand-driven increase in working capital Short-term focus on: − Capacity expansion in OEM businesses − Execution of strong order backlog − Review of current strategy − Address growth opportunities besides semi in optical communication for data centers, defense, expansion of SMS business in US, and AR/VR Revenue and EBITDA margin now expected in upper half of previous guidance ranges Semiconductor & Advanced Manufacturing Biophotonics Metrology & Production Solutions Smart Mobility Solutions
Page 5
2.01 5,11 3.10 7,88 3.32 8,43 6.23 15,83 6.23 15,82 Continued high order intake momentum, supported, among other things, by major orders 5 Order intake in MEUR − Semiconductor & Advanced Manufacturing: strong demand both in the lithography and inspection businesses (incl. major order in Q1) − Biophotonics: substantially higher demand in defense as well as medtech & life science business, major multi-year medtech order in Q2 − Metrology & Production Solutions: order intake in line with expectations − Smart Mobility Solutions: more new orders, among others in North America − Book-to-bill ratio 1.44 (prior year: 0.95) − Order backlog grew substantially to 824.8 million euros (31.12.2025: 590.8 million euros); 60-65% expected to be converted into revenue over the year First half-year 202612.08.2026 In million euros H1/2026 H1/2025 Change in % Semiconductor & Advanced Manufacturing 350.3 189.0 85.3 Biophotonics 163.9 113.1 44.9 Metrology & Production Solutions 111.7 99.8 11.9 Smart Mobility Solutions 75.6 64.6 17.1 Other 21.9 6.2 253.1 204.6 356.9 268.1 366.6 0 200 400 600 800 H1/2025 H1/2026 53.0% 472.7 723.4 Q1 Q2
Page 6
2.01 5,11 3.10 7,88 3.32 8,43 6.23 15,83 6.23 15,82 H1/2026: revenue slightly above prior year 6 Revenue in MEUR − Semiconductor & Advanced Manufacturing: stronger revenue in particular in lithography and inspection − Biophotonics: higher revenue in defense; high comps in medtech due to dental business − Metrology & Production Solutions: automotive market remains challenging − Smart Mobility Solutions: strong development in almost all regions − 77.8% of revenue generated abroad (prior year: 73.6%) First half-year 202612.08.2026 In million euros H1/2026 H1/2025 Change in % Semiconductor & Advanced Manufacturing 230.4 209.1 10.2 Biophotonics 113.9 119.2 –4.5 Metrology & Production Solutions 79.7 92.0 –13.4 Smart Mobility Solutions 68.3 61.7 10.7 Other 10.9 16.4 –33.1 243.6 241.2 254.8 262.0 0 200 400 600 H1/2025 H1/2026 498.4 503.2 1.0% Q2 Q1
Page 7
2.01 5,11 3.10 7,88 3.32 8,43 6.23 15,83 6.23 15,82 EBITDA margin increased to 19.7% compared to modest prior-year level of 15.8% 7 EBITDA in MEUR − Cost-cutting measures implemented in 2025 − Semiconductor & Advanced Manufacturing: better utilization and change in product mix (prior year: costs for move in Dresden included) − Biophotonics: strong profitability retained despite lower revenues − Metrology & Production Solutions: below prior-year level due to lower revenue − Smart Mobility Solutions: positive development driven by higher revenue and lower R+D expenses First half-year 202612.08.2026 EBITDA in million euros EBITDA in % H1/2026 H1/2025 H1/2026 H1/2025 Semiconductor & Advanced Manufacturing 74.5 47.9 31.8 22.2 Biophotonics 24.9 25.4 21.7 21.2 Metrology & Production Solutions –1.1 0.1 –1.3 0.1 Smart Mobility Solutions 9.4 5.8 13.7 9.4 Other –8.8 –0.4 – – 36.2 44.4 42.6 54.5 0 30 60 90 120 H1/2025 H1/2026 25.5% 78.8 98.9 Q2 Q1
Page 8
2.01 5,11 3.10 7,88 3.32 8,43 6.23 15,83 6.23 15,82 Earnings figures significantly improved year-on-year First half-year 2026 8 In million euros H1/2026 H1/2025 Change in % Revenue 503.2 498.4 1.0 Gross margin 36.1% 31.2% Functional costs 119.9 115.6 3.7 Other operating result 0.1 −0.4 n.a. EBITDA 98.9 78.8 25.5 EBIT 61.9 39.6 56.3 Financial result −6.0 −7.8 22.1 Earnings before tax 55.9 31.9 75.4 Earnings after tax 39.7 25.3 57.1 Earnings per share (euros) 0.69 0.42 64.3 − Gross margin improved in particular by higher contribution of Semiconductor & Advanced Manufacturing − Functional cost ratio amounted to 23.8% (prior year: 23.2%) ▪ R+D expense ratio: 6.6% (prior year: 6.2%) ▪ Selling expense ratio: 9.9% (prior year: 10.2%) ▪ Administrative expense ratio: 7.3% (prior year: 6.7%) − EBIT margin increased to 12.3% (prior year 8.0%) − Financial result influenced by an improved net balance of foreign exchange gains and losses − Tax rate at 29.0% (prior year: 28.8%) ▪ Tax rate without deferred taxes of 22.1% (prior year: 26.8%) 12.08.2026 *Group = continuing operations + discontinued operation (VINCORION)
Page 9
2.01 5,11 3.10 7,88 3.32 8,43 6.23 15,83 6.23 15,82 Free cash flow influenced by increase in working capital; financial position remains robust First half-year 2026 9 − Cash flows from operating activities impacted by demand-driven increase (prior year: reduction) in working capital − Cash flows from operative investing activities influenced in particular by payments for property, plant and equipment − Cash conversion rate at 47.7% (prior year: 54.9%) − Leverage: 1.4x (net debt to EBITDA / 31.12.2025: 1.6x) − Capital expenditure amounted to 19.7 million euros (prior year 32.6 million euros) − Working capital ratio at 32.3% (31.12.2025: 29.1% / 30.6.2026: 30.3%) In million euros H1/2026 H1/2025 Change in % Cash flows from operating activities before income taxes 68.8 81.3 −15.3 Cash flows from operative investing activities −21.7 −38.0 43.1 Free cash flow (before interest and income tax payments) 47.2 43.2 9.1 Net debt 307.5 317.4* −3.1 Equity ratio 58.4% 60.2%* n.a. 12.08.2026 *31.12.2025
Page 10
2.01 5,11 3.10 7,88 3.32 8,43 6.23 15,83 6.23 15,82 Outlook
Page 11
2.01 5,11 3.10 7,88 3.32 8,43 6.23 15,83 6.23 15,82 Revenue and EBITDA margin for 2026 now expected in upper half of previous guidance ranges 12.08.2026 First half-year 2026 11 − Revenue increase in upper half of previous guidance range (previously: single- digit percentage range / 2025: 1,046.0 million euros) − EBITDA margin 20.0 to 21.0 percent (before between 19.0 and 21.0 percent / 2025: 18.4%) − Investments slightly below prior year (2025: 77.4 million euros) Targets 2026 The guidance is subject to the assumption that political and economic conditions do not deteriorate, including in particular economic trends, the war in Ukraine, the conflict in the Middle East, European and international regulations, and macroeconomic developments. Potential portfolio changes are not considered in this forecast. Semiconductor & Advanced Manufacturing Biophotonics Metrology & Production Solutions Smart Mobility Solutions
Page 12
2.01 5,11 3.10 7,88 3.32 8,43 6.23 15,83 6.23 15,82 Appendix
Page 13
2.01 5,11 3.10 7,88 3.32 8,43 6.23 15,83 6.23 15,82 New organizational and reporting structure 12.08.2026 First half-year 2026 13 Semiconductor & Advanced Manufacturing Biophotonics Metrology & Production Solutions Smart Mobility Solutions − Optical and micro- optical components for the semiconductor equipment industry − Information and communication technologies and other industrial applications − Optical components for life science & medical technology industry − Various industrial applications (incl. security and defense) − Systems and service for inspection, metrology and production solutions for optical, electronics and automotive industries − Camera systems and services for traffic surveillance, civil security and roads user charging Greater customer focus, more efficiency and clearer responsibilities
Page 14
2.01 5,11 3.10 7,88 3.32 8,43 6.23 15,83 6.23 15,82 Dates and contact 14 12.08.2026 Result of first half-year 2026 01.09.2026 Coba ODDO Conference, Frankfurt/Main (IR) 02.09.2026 dbAccess Conference, London (IR) 8.-9.9.2026 Roadshow USA (CFO/IR) 16.9.2026 Roadshow Lugano / Milano (IR) 21.09.2026 Baader Conference, Munich (CEO/CFO/IR) 22.09.2026 Berenberg Conference, Munich (CEO/CFO/IR) Andreas Theisen Head of Investor Relations JENOPTIK AG Phone: +49 3641 65-2291 andreas.theisen@jenoptik.com https://www.jenoptik.com https://www.linkedin.com/company/jenoptik/ https://www.instagram.com/jenoptik_group/ First half-year 2026 12.08.2026 Sabine Barnekow Investor Relations Manager JENOPTIK AG Phone: +49 3641 65-2156 sabine.barnekow@jenoptik.com